BR100 Decreased By (-0.47%)
BR30 Decreased By (-0.77%)
KSE100 Decreased By (-0.38%)
KSE30 Decreased By (-0.35%)
AGHA 6.56 Decreased By ▼ -0.11 (-1.65%)
BECO 4.40 Increased By ▲ 0.05 (1.15%)
BML 55.25 Decreased By ▼ -0.92 (-1.64%)
BOP 29.87 Decreased By ▼ -0.25 (-0.83%)
CNERGY 12.70 Decreased By ▼ -0.28 (-2.16%)
CSIL 5.19 Decreased By ▼ -0.12 (-2.26%)
FCCL 51.20 Decreased By ▼ -0.45 (-0.87%)
FFL 14.40 Decreased By ▼ -0.09 (-0.62%)
FNEL 1.18 Decreased By ▼ -0.03 (-2.48%)
KEL 5.99 Decreased By ▼ -0.07 (-1.16%)
KOSM 5.56 Decreased By ▼ -0.28 (-4.79%)
LOTCHEM 26.19 Increased By ▲ 0.02 (0.08%)
MLCF 90.00 Decreased By ▼ -1.23 (-1.35%)
NBP 162.27 Decreased By ▼ -1.92 (-1.17%)
NCPL 52.70 Decreased By ▼ -0.48 (-0.9%)
NPL 58.00 Decreased By ▼ -1.12 (-1.89%)
OGDC 314.00 Increased By ▲ 0.61 (0.19%)
PACE 9.68 Decreased By ▼ -0.09 (-0.92%)
PAEL 34.91 Decreased By ▼ -0.33 (-0.94%)
PIBTL 14.19 Decreased By ▼ -0.52 (-3.54%)
PPL 219.40 Decreased By ▼ -1.96 (-0.89%)
PRL 89.95 Decreased By ▼ -1.27 (-1.39%)
PTC 59.25 Increased By ▲ 0.06 (0.1%)
SSGC 23.23 Decreased By ▼ -0.07 (-0.3%)
TBL 8.68 Decreased By ▼ -0.07 (-0.8%)
TELE 7.38 Decreased By ▼ -0.23 (-3.02%)
TPL 21.10 Decreased By ▼ -0.93 (-4.22%)
TPLP 12.13 Decreased By ▼ -0.43 (-3.42%)
TREET 21.40 Decreased By ▼ -0.33 (-1.52%)
TRG 54.26 Decreased By ▼ -1.53 (-2.74%)
Markets

CBOT soybeans to test resistance at $12.69-1/4

8 The contract is riding on a wave 3 that is travelling towards the range of $12.69-1/4 to $12.77-3/4, formed by its 338.2% and 361.8% projection levels.
Published Updated
By

SINGAPORE: The CBOT soybean January contract is expected to test a resistance at $12.69-1/4 per bushel, with a good chance of breaking above this level and rising towards $12.77-3/4.

The contract is riding on a wave 3 that is travelling towards the range of $12.69-1/4 to $12.77-3/4, formed by its 338.2% and 361.8% projection levels.

Support is at $12.61, a break below which may cause a fall into $12.51-$12.56 range.

Each reader should consult his or her own professional or other advisers for business, financial or legal advice regarding the products mentioned in the analyses.

Comments

Comments are closed for this article.